<?xml version="1.0" encoding="UTF-8"?>
<p>Prior to the advent of vaccination, the incidence rate of measles was so high that infection by the measles virus was basically considered an inevitability [
 <xref rid="B23-viruses-12-00520" ref-type="bibr">23</xref>,
 <xref rid="B24-viruses-12-00520" ref-type="bibr">24</xref>]. The virus, which is spread by the respiratory route, is highly contagious and infects over 90% of individuals by age 18 in the pre-vaccination era [
 <xref rid="B24-viruses-12-00520" ref-type="bibr">24</xref>,
 <xref rid="B25-viruses-12-00520" ref-type="bibr">25</xref>]. About seven to eight million children were estimated to have died from measles infection each year during this period, with many others suffering from disease complications [
 <xref rid="B26-viruses-12-00520" ref-type="bibr">26</xref>]. However, in 1936, society experienced a turning point in the fight against measles with the development of the first live-attenuated measles vaccine (MV) [
 <xref rid="B27-viruses-12-00520" ref-type="bibr">27</xref>].
</p>
